Where Are The Opportunities For A Brexit Bonanza?

Where Are The Opportunities For A Brexit Bonanza? By Nick Sudbury The shock decision by the British people to vote to leave the European Union created havoc on the financial markets when the result of the referendum was announced on June 24. The two main casualties were the sterling dollar exchange rate and the FTSE 250 index that is dominated by domestically focused UK-listed companies. Those who invest in managed funds are normally fairly well protected against massive price swings by the diversification of the underlying holdings, but analysis by FE Trustnet shows that 17 open-ended funds made returns in excess of 10% on Brexit Friday, while another 50 fell by 7.96% or more. It is well worth having a look at the data as it makes interesting reading. The top performers were mainly funds that invest in the American stock market or gold producers that benefited from the 10% fall in the value of sterling against the US dollar. At the other end of the scale the worst performers were mostly small and mid-cap funds with exposure to UK companies that would suffer in the event of a recession ... Click Here To Read The Full Story The Master Investor Market Report The FTSE 100 closed the day at 6,545.37 an increase of 23.11 points. The FTSE 250 fell 382.02 points to finish at 15,734.68. The FTSE All Share dropped 4.50 points to finish at 3,514.46. The FTSE AIM All Share finished at 705.57, down by 8.11 points. Housebuilder Persimmon (PSN) has said that it is too soon to judge the impact that Brexit will have on the residential property market, but reassured investors that trading during the first half of 2016 had been strong with completions and average sales prices both rising by 6% relative to 2015. Forward sales levels are in line with the same point of last year, despite the company making a decision to release properties onto the market later in the construction process. Persimmon shares fell 103p to 1,332p.   Download our July issue today! Click HERE to read. Microchip designer Imagination Technologies (IMG) saw its revenues for the year ended 30th April drop by more than 20% to £120 million as licensing and royalty income both fell. The firm's statutory loss before tax widened to £87 million from £12 million in the prior year. A significant restructuring plan has begun that will focus the company on three core computing areas and targetting £27.5 million in cost base reductions for the 2017 financial year. Imagination Technologies shares dropped by 8.17% to 168.50p. Landscaping products specialist Marshalls (MSLH) has increased its revenues by 2% to £202 million during the 6 months ended 5th July on the back of strong sales performances in May and June. Order books for the immediate future are also ahead of last year with good demand from both the public and private sectors, and management said that the longer run outlook was good. Shares in Marshalls declined by 17.30p to 213.10p. Tomorrow's news today Booker Group (BOK) will release trading statements. Quote of the day "I believe in luck: how else can you explain the success of those you dislike?" -Jean Cocteau Latest Stories Chart Of The Day: GlaxoSmithKline By Zak Mir Is the pharmaceutical giant a galloping elephant? A look at a suprising story of blue chip stock that's rapidly improving and where its limits might lie… Click Here To Read The Full Story Rio Tinto Shares - From Bombed Out to Fair Value By Robert Sutherland Smith Rio Tinto has benefitted in recent weeks as the fall in the Pound benefitted its international earnings and is well above its bombed out value seen earlier this year. Is it time to reassess our opinion of the company long known as RTZ? … Click Here To Read The Full Story Debt-Free Dividend Investing By John Kingham Excessive debts are one of the top reasons for firms to cut dividend. How can you still reap high rewards as a dividend investor whilst avoiding highly indebted firms and what warning signs should you look out for?… Click Here To Read The Full Story Forget "Pharmaceuticals" – Think Immunology and Synthetic Biology By Victor Hill What should investors think about when they think about Biotech? It's time to move beyond wonder drugs and look in to immunotherapy and synthetic biology… Click Here To Read The Full Story Chart of the Day: Moneysupermarket By Zak Mir When one looks beyond the annoying television adverts, how does the investment case for Moneysupermarket hold up... Click Here To Read The Full Story   Join the movement on social media: Copyright 2016 Master Investor Ltd, All rights reserved. You are receiving this email because you opted in at our website. If a Daily Bulletin is too frequent, why not opt in to our once weekly mailing list for a round up of the week's news straight to your inbox. Once Weekly Round-Up Our mailing address is: Suite 88, 22 Notting Hill Gate, London W11 3JE Master Investor is a trading name of Master Investor Limited. Material contained within Master Investor Magazine and its website is for general information purposes only and is not intended to be relied upon by individual readers in making (or refraining from making) any specific investment decisions. Master Investor Ltd does not accept any liability for any losses suffered by any user as a result of any such decision.

This email was sent to educationspeculator.davinci@blogger.com why did I get this?    unsubscribe from this list    update subscription preferences Master Investor Ltd · Suite 88 · 22 Notting Hill Gate · London, London W11 3JE · United Kingdom